Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / RARE - Ultragenyx: Convincing Investment Thesis For This Orphan Drug Developer

RARE - Ultragenyx: Convincing Investment Thesis For This Orphan Drug Developer

Ultragenyx Pharmaceutical Inc.
  • Ultragenyx is a rare disease drug developer.
  • Its execution, so far, has been near perfect.
  • The company has a long pipeline and oodles of cash.

For further details see:

Ultragenyx: Convincing Investment Thesis For This Orphan Drug Developer
Stock Information
Company Name: Ultragenyx Pharmaceutical Inc.
Stock Symbol: RARE
Market: NASDAQ
Website: ultragenyx.com
Menu
RARE RARE Quote RARE Short RARE News RARE Articles RARE Message Board
Get RARE Alerts

News, Short Squeeze, Breakout and More Instantly...